Report for: Allergen injection immunotherapy for seasonal allergic rhinitis

Title	Allergen injection immunotherapy for seasonal allergic rhinitis
Published in	Cochrane database of systematic reviews, January 2007
DOI	10.1002/14651858.cd001936.pub2
Pubmed ID	17253469
Authors	Moises A Calderon, Bernadette Alves, Mikila Jacobson, Brian Hurwitz, Aziz Sheikh, Stephen Durham
Abstract	Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms remain uncontrolled despite medical treatment, allergen injection immunotherapy is advised. An allergen-based treatment may reduce symptoms, the need for medication and modify the natural course of this disease.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
France	1	100%

Demographic breakdown

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 245 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Germany	2	<1%
Austria	1	<1%
Canada	1	<1%
Egypt	1	<1%
Denmark	1	<1%
United States	1	<1%
Unknown	238	97%

Demographic breakdown

Readers by professional status	Count	As %
Other	34	14%
Researcher	31	13%
Student > Master	29	12%
Student > Bachelor	29	12%
Student > Ph. D. Student	20	8%
Other	50	20%
Unknown	52	21%

Readers by discipline	Count	As %
Medicine and Dentistry	120	49%
Agricultural and Biological Sciences	22	9%
Nursing and Health Professions	13	5%
Biochemistry, Genetics and Molecular Biology	8	3%
Immunology and Microbiology	7	3%
Other	19	8%
Unknown	56	23%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2022.

All research outputs

#2,920,244

of 23,498,521 outputs

Outputs from Cochrane database of systematic reviews

#5,731

of 12,714 outputs

Outputs of similar age

#11,803

of 163,895 outputs

Outputs of similar age from Cochrane database of systematic reviews

#17

of 67 outputs

Altmetric has tracked 23,498,521 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,714 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.0. This one has gotten more attention than average, scoring higher than 54% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,895 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.

We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.

Cochrane Database of Systematic Reviews

Allergen injection immunotherapy for seasonal allergic rhinitis

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context